Valeant Pharmaceuticals Announces 2015 Annual Meeting Results

May 19, 2015, 17:00 ET from Valeant Pharmaceuticals International, Inc.

LAVAL, Quebec, May 19, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced the election of eleven directors nominated at its 2015 annual meeting of shareholders today.  The detailed results of the vote for the election of directors are set out below: 

Name

For

Withheld

Broker Non-Votes

Ronald H. Farmer

259,517,209

2,064,596

12,938,661

Colleen A. Goggins

260,564,263

1,017,542

12,938,661

Robert A. Ingram

258,725,145

2,856,660

12,938,661

Anders Lönner

259,632,031

1,949,774

12,938,661

Theo Melas-Kyriazi

260,811,015

770,790

12,938,661

J. Michael Pearson

255,809,687

5,772,118

12,938,661

Robert N. Power

258,849,981

2,731,824

12,938,661

Norma A. Provencio

260,777,276

804,529

12,938,661

Howard B. Schiller

250,437,448

11,144,357

12,938,661

Katharine B. Stevenson

260,656,695

925,110

12,938,661

Jeffrey W. Ubben

260,166,082

1,415,723

12,938,661

 

At the annual meeting, shareholders also approved the non-binding advisory vote on named executive officer compensation as disclosed in the proxy statement and appointed PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm until the close of the Company's 2016 annual meeting of shareholders.

The final vote tabulation on all matters voted on at today's meeting will be reported to the U.S. Securities and Exchange Commission on a current report on Form 8-K and such report will be made available on the Company's web site, www.valeant.com.

About Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology  and branded generics. More information about Valeant can be found at www.valeant.com.

Contact Information: Laurie W. Little 949-461-6002 laurie.little@valeant.com

Logo - http://photos.prnewswire.com/prnh/20101025/LA87217LOGO

 

SOURCE Valeant Pharmaceuticals International, Inc.



RELATED LINKS

http://www.valeant.com